These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18411317)

  • 1. Susceptibility of Chlamydia trachomatis to the excipient hydroxyethyl cellulose: pH and concentration dependence of antimicrobial activity.
    Sater AA; Ojcius DM; Meyer MP
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2660-2. PubMed ID: 18411317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal Gel Component Hydroxyethyl Cellulose Significantly Enhances the Infectivity of
    Raffai T; Burián K; Janovák L; Bogdanov A; Hegemann JH; Endrész V; Virok DP
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of Chlamydia trachomatis infection in environments mimicking normal and abnormal vaginal pH.
    Yasin B; Pang M; Wagar EA; Lehrer RI
    Sex Transm Dis; 2002 Sep; 29(9):514-9. PubMed ID: 12218842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.
    Neurath AR; Strick N; Li YY; Lin K; Jiang S
    Biologicals; 1999 Mar; 27(1):11-21. PubMed ID: 10441398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Resistance Screening in Chlamydia trachomatis by Optimized McCoy Cell Culture System and Direct qPCR-Based Monitoring of Chlamydial Growth.
    Meštrović T; Virok DP; Ljubin-Sternak S; Raffai T; Burián K; Vraneš J
    Methods Mol Biol; 2019; 2042():33-43. PubMed ID: 31385269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
    Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
    J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal microbicides can interfere with nucleic acid amplification tests used for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae infection.
    Crucitti T; Jespers V; Van Damme L; Van Dyck E; Buvé A
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):97-9. PubMed ID: 16860515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of antiseptics on Chlamydia trachomatis growth.
    Párducz L; Eszik I; Wagner G; Burián K; Endrész V; Virok DP
    Lett Appl Microbiol; 2016 Oct; 63(4):260-7. PubMed ID: 27472980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Chlamydia trachomatis Growth During the Last Decade: A Mini-Review.
    Serradji N; Vu TH; Kim H; Panyam J; Verbeke P
    Mini Rev Med Chem; 2018; 18(16):1363-1372. PubMed ID: 29692244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of
    Mestrovic T; Ljubin-Sternak S
    Front Biosci (Landmark Ed); 2018 Jan; 23(4):656-670. PubMed ID: 28930567
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial susceptibilities of Chlamydia trachomatis isolated from the urethra and pharynx of Japanese males.
    Kai S; Wada K; Sadahira T; Araki M; Ishii A; Watanabe T; Monden K; Uno S; Araki T; Nasu Y
    J Infect Chemother; 2017 Aug; 23(8):512-516. PubMed ID: 28476331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India.
    Bhengraj AR; Vardhan H; Srivastava P; Salhan S; Mittal A
    Chemotherapy; 2010; 56(5):371-7. PubMed ID: 20938174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection.
    Shao L; You C; Cao J; Jiang Y; Liu Y; Liu Q
    Int J Infect Dis; 2020 Jul; 96():121-127. PubMed ID: 32173573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of roxithromycin against Chlamydia trachomatis.
    Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
    J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clinically relevant culture conditions on antimicrobial susceptibility of Chlamydia trachomatis.
    Wyrick PB; Davis CH; Raulston JE; Knight ST; Choong J
    Clin Infect Dis; 1994 Nov; 19(5):931-6. PubMed ID: 7893882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determining antimicrobial resistance to Chlamydia trachomatis and applying present findings in daily practice].
    Sternak SL; Skerk V
    Med Glas (Zenica); 2010 Feb; 7(1):26-31. PubMed ID: 20387721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bovine lactoferrin on Chlamydia trachomatis infection and inflammation.
    Sessa R; Di Pietro M; Filardo S; Bressan A; Rosa L; Cutone A; Frioni A; Berlutti F; Paesano R; Valenti P
    Biochem Cell Biol; 2017 Feb; 95(1):34-40. PubMed ID: 28094551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of fifteen Chlamydia trachomatis strains isolated in Greece.
    Mentis AF; Tzouvelekis LS; Mavrommati L
    J Antimicrob Chemother; 1989 Jul; 24(1):94. PubMed ID: 2777733
    [No Abstract]   [Full Text] [Related]  

  • 19. The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro.
    Wyrick PB; Knight ST; Gerbig DG; Raulston JE; Davis CH; Paul TR; Malamud D
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1335-44. PubMed ID: 9174195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolino 2-Pyridone Amide Inhibitors of Chlamydia trachomatis Infectivity.
    Good JA; Silver J; Núñez-Otero C; Bahnan W; Krishnan KS; Salin O; Engström P; Svensson R; Artursson P; Gylfe Å; Bergström S; Almqvist F
    J Med Chem; 2016 Mar; 59(5):2094-108. PubMed ID: 26849778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.